EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prescribing and dosing patterns of ferric carboxymaltose for iron deficiency anemia: a real-world study from Saudi Arabia

Yahya A Alzahrani, Ayed A Alkatheeri, Abdulrahman B Alshamrani, Abdullah M Alzahrani, Thamer M A Alqurashi, Maan H Harbi, Rajaa Al-Raddadi

Frontiers in Medicine · 07.08.2026 · 13

DOI: 10.3389/fmed.2026.1864516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 07.08.2026. Verfasst von Yahya A Alzahrani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ferric carboxymaltose (FCM) is increasingly used for iron deficiency anemia, yet real-world prescribing patterns and dosing appropriateness remain poorly characterized, particularly in regions with high anemia prevalence. This study evaluated FCM prescribing patterns, dosing appropriateness, and associated clinical and financial implications at a Saudi tertiary hospital.

Methods

This retrospective observational study examined adult patients who received FCM at a tertiary care general hospital in Saudi Arabia over a 6-month period. Dosing appropriateness was determined by comparing prescribed cumulative doses (PCD) with calculated cumulative doses (CCD) per the Summary of Product Characteristics. Hemoglobin response and financial impact were also assessed.

Results

Of 182 patients treated with FCM, 79 met the inclusion criteria (97.5% female; mean age 34.6 ± 8.3 years). Overall, 82% of prescriptions exhibited an inappropriate cumulative dose, with 88% subtherapeutic. Mean PCD (1,118 ± 492 mg) was substantially lower than CCD (1,640 ± 438 mg), a mean under-dosing gap of 522.6 mg ( p < 0.001). In addition, 63.3% of patients were iron-therapy naïve. Hemoglobin response was reduced (1.35 g/dL rise) versus suitably dosed populations (2.5–3.0 g/dL). No predictor of inappropriate dosing reached significance. Projected complication costs (171,055 SAR) substantially exceeded apparent medication savings (19,599 SAR).

Discussion

Widespread subtherapeutic FCM dosing compromises therapeutic outcomes and increases downstream costs. Implementation of electronic clinical decision support and standardized dosing protocols is urgently needed to optimize intravenous iron utilization.

Schlagwörter

Stichwörter der Autor:innen

Saudi Arabiadosing appropriatenessferric carboxymaltoseiron deficiency anemiaprescribing patterns

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
  • Drug Information Center, Pharmacy Department, East Jeddah Hospital, Jeddah First Health Cluster, Jeddah, Saudi Arabia.
  • Clinical Pharmacy Unite, Pharmacy Department, East Jeddah Hospital, Jeddah First Health Cluster, Jeddah, Saudi Arabia.
  • Pharmaceutical Care Department, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia.
  • Pharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Preventive Medicine and Public Health, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Förderung

  • King Abdulaziz University

Zitieren

APA

Alzahrani, Y. A., Alkatheeri, A. A., Alshamrani, A. B., Alzahrani, A. M., Alqurashi, T. M. A., Harbi, M. H., & Al-Raddadi, R. (2026). Prescribing and dosing patterns of ferric carboxymaltose for iron deficiency anemia: a real-world study from Saudi Arabia. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1864516

Vancouver

Alzahrani YA, Alkatheeri AA, Alshamrani AB, Alzahrani AM, Alqurashi TMA, Harbi MH, et al. Prescribing and dosing patterns of ferric carboxymaltose for iron deficiency anemia: a real-world study from Saudi Arabia. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1864516

BibTeX
@article{Alzahrani2026,
  author = {Alzahrani, Yahya A and Alkatheeri, Ayed A and Alshamrani, Abdulrahman B and Alzahrani, Abdullah M and Alqurashi, Thamer M A and Harbi, Maan H and Al-Raddadi, Rajaa},
  title = {Prescribing and dosing patterns of ferric carboxymaltose for iron deficiency anemia: a real-world study from Saudi Arabia},
  journal = {Frontiers in Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fmed.2026.1864516}
}
Kostenlos starten →